Screener
Revolution Medicines, Inc. RVMD Net Income
Net Income at other companies
Other financials
Where this comes from
Reported directly by Revolution Medicines, Inc. in its filing.
Tagged under the XBRL concept us-gaap:NetIncomeLoss.
The source filing: Revolution Medicines, Inc.’s 10-Q, filed August 5, 2026. Open the filing →
- Filed
- Aug 5, 2026, 4:10 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-335104
FAQ
- What is Revolution Medicines, Inc.'s net income?
- Revolution Medicines, Inc. (RVMD) reported net income of -$644.37M in Q2 2026.
- How has Revolution Medicines, Inc.'s net income changed year-over-year?
- Revolution Medicines, Inc.'s net income decreased by 160.1% year-over-year, from -$247.79M to -$644.37M.
- What is the long-term trend for Revolution Medicines, Inc.'s net income?
- Over 4 years (2021 to 2025), Revolution Medicines, Inc.'s net income has grown at a 56.8% compound annual growth rate (CAGR), from -$187.09M to -$1.13B.
- What does net income mean?
- The bottom line — total revenue minus all expenses, taxes, and costs. Represents the profit attributable to the company's shareholders after all obligations are met.
Ask your AI about Revolution Medicines, Inc.'s net income.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude